Role of Whole-exome Sequencing in Phenotype Classification and Clinical Treatment of Pediatric Restrictive Cardiomyopathy
- Author:
- No author available
- Journal Title:
- Chinese Medical Journal
- Issue:
- 23
- DOI:
- 10.4103/0366-6999.219150
- Key Word:
- Pediatric Restrictive Cardiomyopathy;Phenotype Classification;TNNI3;Whole-exome Sequencing
Abstract： Background: Restrictive cardiomyopathy (RCM) is the least common cardiomyopathy in which the walls are rigid and the heart is restricted from stretching and filling properly. Cardiac troponin I (cTnI) mutation-caused myofibril Ca2+ hypersensitivity has been shown to be associated with impaired diastolic function. This study aimed to investigate the linkage between the genotype and clinical therapy of RCM. Methods: Five sporadic pediatric RCM patients confirmed by echocardiography were enrolled in this study.Whole-exome sequencing (WES) was performed for the cohort to find out candidate causative gene variants. Sanger sequencing confirmed the WES-identified variants. Results: TNNI3 variants were found in all of the five patients. R192H mutation was shared in four patients while R204H mutation was found only in one patient. Structure investigation showed that the C terminus of TNNI3 was flexible and mutation on the C terminus was possible to cause the RCM. Catechins were prescribed for the five patients once genotype was confirmed. Ventricular diastolic function was improved in three patients during the follow-up. Conclusions: Our data demonstrated that TNNI3 mutation-induced RCM1 is the most common type of pediatric RCM in this study. In addition, WES is a reliable approach to identify likely pathogenic genes of RCM and might be useful for the guidance of clinical treatment scheme.
- [1]Muchtar, Eli,Blauwet, Lori A.,Gertz, Morie A..Restrictive Cardiomyopathy Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy[J].2017,121(7).
- [2]Soichi, Takeda,Atsuko, Yamashita,Kayo, Maeda,etc.Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form.[J].2003,424(6944).
- [3]Li,Y.,Zhang,L.,Jean-Charles,P.-Y.,etc.Dose-dependent diastolic dysfunction and early death in a mouse model with cardiac troponin mutations[J].2013,62.
- [4]Kai,Wang.ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.[J].2010,38.
- [5]Russo, L. M.,Webber, S. A..Idiopathic restrictive cardiomyopathy in chlidren.[J].2005,91(9).
- [6]Wu G,Tian J,Jin JP,etc.Correcting diastolic dysfunction by Ca2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy.[J].2010,49(3).
- [7]Zhang, Lei,Nan, Changlong,Chen, Yuan,etc.Calcium desensitizer catechin reverses diastolic dysfunction in mice with restrictive cardiomyopathy[J].2015,573.
- [8]Balfour IC,Chen SC,Jureidini S.Clinical spectrum of restrictive cardiomyopathy in children.[J].2001,20(1).
- [9]Xu-Pei Huang,Jian-feng DU.Troponin Ⅰ, cardiac diastolic dysfunction and restrictive cardiomyopathy[J].2004,(12).
- [10]Fricker FJ,Wallace MR,Kaplan L,etc.Genetic linkage of a novel autosomal dominant restrictive cardiomyopathy locus.[J].2005,42(8).
- [11]Sara L, Van Driest,Erik G, Ellsworth,Steve R, Ommen,etc.Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy.[J].2003,108.
- [12]S, Ishiwata,S, Nishiyama,A, Seki,etc.Restrictive cardiomyopathy with complete atrioventricular block and distal myopathy with rimmed vacuoles.[J].1993,57.
- [13]Peddy SB,Vricella LA,Crosson JE,etc.Infantile restrictive cardiomyopathy resulting from a mutation in the cardiac troponin T gene.[J].2006,117(5).
- [14]Shamil R Sunyaev,Leonid Peshkin,Ivan A Adzhubei,etc.A method and server for predicting damaging missense mutations[J].2010,7(4).
- [15]Choi, Yongwook,Chan, Agnes P..PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels[J].2015,31(16).
- [16]Brodehl, Andreas,Ferrier, Raechel A.,Hamilton, Sara J.,etc.Mutations in FLNC are Associated with Familial Restrictive Cardiomyopathy[J].2016,37(3).
- [17]Elliott P,Andersson B,Arbustini E,etc.Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.[J].2008,29(2).
- [18]Chinali M,Aurigemma GP,de Simone G.Mitral E wave deceleration time to peak E velocity ratio and cardiovascular outcome in hypertensive patients during antihypertensive treatment (from the LIFE echo-substudy).[J].2009,104(8).
- [19]McKenna A,Hanna M,Banks E,etc.The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.[J].2010,20(9).
- [20]Weintraub RG,Cheung M,Daubeney PE,etc.The epidemiology of childhood cardiomyopathy in Australia.[J].2003,348(17).
- [21]Meyer,T.,Ruppert,V.,Ackermann,S.,etc.Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardiomyopathy[J].2013,21(3).
- [22]Ohki S,Murakami K,Yumoto F,etc.Structural basis for Ca2+-regulated muscle relaxation at interaction sites of troponin with actin and tropomyosin[J].2005,352(1).
- [23]Mogensen J,Kubo T,Duque M,etc.Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations.[J].2003,111(2).
- [24]Ivan, Malci?,Marija, Jelusi?,Hrvoje, Kniewald,etc.Epidemiology of cardiomyopathies in children and adolescents: a retrospective study over the last 10 years.[J].2002,12.